Figure 2.
The percentage of children with growth hormone concentrations greater than or equal to thresholds of 5, 7 or 10 ng/ml at the time of glucagon administration at the end of the diagnostic fasting study (n=29), or 30 (n=16), 60 (n=18), 90 (n=27), 120 (n=27), 150 (n=21), 180 (n=7) or 210 (n=3) minutes later.
